Free Trial
NYSE:NEUE

NeueHealth (NEUE) Stock Price, News & Analysis

NeueHealth logo
$6.78 -0.07 (-0.95%)
Closing price 08/7/2025 03:58 PM Eastern
Extended Trading
$6.78 0.00 (0.00%)
As of 08/7/2025 04:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeueHealth Stock (NYSE:NEUE)

Key Stats

Today's Range
$6.73
$6.85
50-Day Range
$6.75
$6.92
52-Week Range
$3.79
$7.66
Volume
4,910 shs
Average Volume
5,284 shs
Market Capitalization
$60.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Hold

Company Overview

NeueHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

NEUE MarketRank™: 

NeueHealth scored higher than 41% of companies evaluated by MarketBeat, and ranked 805th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    NeueHealth has received no research coverage in the past 90 days.

  • Read more about NeueHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeueHealth is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeueHealth is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.23% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeueHealth has recently decreased by 41.79%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    NeueHealth does not currently pay a dividend.

  • Dividend Growth

    NeueHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.23% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeueHealth has recently decreased by 41.79%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    NeueHealth has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for NeueHealth this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for NEUE on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,948.00 in company stock.

  • Percentage Held by Insiders

    63.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about NeueHealth's insider trading history.
Receive NEUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter.

NEUE Stock News Headlines

GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.
Transcript : NeueHealth, Inc., Q2 2025 Earnings Call, Aug 07, 2025
NeueHealth Reports Second Quarter 2025 Results
NeueHealth Reports Second Quarter 2025 Results
NeueHealth (NEUE) Expected to Announce Earnings on Thursday
See More Headlines

NEUE Stock Analysis - Frequently Asked Questions

NeueHealth's stock was trading at $7.42 at the beginning of 2025. Since then, NEUE shares have decreased by 8.7% and is now trading at $6.7750.

NeueHealth, Inc. (NYSE:NEUE) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($1.80) earnings per share for the quarter, beating the consensus estimate of ($2.51) by $0.71. The company earned $215.79 million during the quarter, compared to analysts' expectations of $249.50 million.
Read the conference call transcript
.

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT).

Company Calendar

Last Earnings
5/08/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Insurance
Current Symbol
NYSE:NEUE
Previous Symbol
NYSE:NEUE
CIK
1671284
Fax
N/A
Employees
1,252
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+3.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($22.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$134.68 million
Net Margins
-14.28%
Pretax Margin
-11.81%
Return on Equity
N/A
Return on Assets
-17.46%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.74
Quick Ratio
0.74

Sales & Book Value

Annual Sales
$936.66 million
Price / Sales
0.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($163.57) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
8,930,000
Free Float
3,277,000
Market Cap
$60.50 million
Optionable
N/A
Beta
0.57
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:NEUE) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners